Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
11:56
Grvt confirms it will announce the full tokenomics in March
According to Odaily, the decentralized contract exchange Grvt has released its 2026 roadmap on X, confirming that the complete tokenomics, including allocation structure, unlocking schedule, and distribution mechanism, will be announced in March. Grvt revealed that holding GRVT will provide the following benefits: 1. Enjoy more favorable fees in perpetual contracts, spot trading, and payment scenarios; 2. Obtain higher returns on deposits deployed in DeFi; 3. Share protocol revenue and have priority participation in new markets and new products.
11:54
Tether's secondary market valuation may reach as high as $375 billion, with its largest shareholder's net worth possibly surpassing that of Warren Buffett.
PANews, February 27 — According to Forbes, secondary market trading indicates that stablecoin issuer Tether may be valued as high as $375 billion, which would place its owners among the wealthiest in the world. Industry sources state that Tether is trading in the secondary market within a price range of $350 billion to $375 billion. Based on conversations with cryptocurrency investors and executives, Forbes currently values Tether at around $200 billion, still far above last year's $50 billion valuation. At a $200 billion valuation, Chief Financial Officer Giancarlo Devasini, who holds approximately 44-45% of shares, would have a fortune of about $89 billion. CEO Paolo Ardoino and former CEO Jean-Louis van der Velde each hold about 19%, making their net worth around $38 billion; General Counsel Stuart Hoegner holds about 12%, with a net worth close to $25 billion. If calculated at the lower end of the secondary market valuation of $350 billion, Devasini's stake would be worth more than $156 billion, enough to rank among the world's top ten richest people, surpassing Buffett's current net worth of $147.8 billion.
11:54
Biotechnology company Zura Bio recently announced the official completion of its public offering totaling $144 million.
In this issuance, the underwriters fully exercised the over-allotment option, demonstrating strong market confidence in the company's development prospects. The injection of these funds will provide important support for Zura Bio to advance its innovative therapy research and development.
News